Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

306 results found

2020 ∙ Mo, Y. Zeng, J. Xiao, C. Zhang, L. Wang, L. Lu, F. Johnson, D. W. Stålsby Lundborg, C. Nitsch, D. Liu, X. Su, G.

Effectiveness and safety of pneumococcal vaccines used alone or combined with influenza vaccination in dialysis patients: A systematic review and meta-analysis

  • All age groups
  • Influenza
  • Pneumococcal disease
  • Administration
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2020 ∙ Onwuchekwa, C. Edem, B. Williams, V. Oga, E.

Estimating the impact of pneumococcal conjugate vaccines on childhood pneumonia in sub-Saharan Africa: A systematic review

  • Africa
  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2020 ∙ Garrido, H. M. G. Schnyder, J. L. Tanck, M. W. T. Vollaard, A. Spijker, R. Grobusch, M. P. Goorhuis, A.

Immunogenicity of pneumococcal vaccination in HIV infected individuals: A systematic review and meta-analysis

  • Adults
  • Older adults
  • Pregnant women
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2020 ∙ Nieto Guevara, J. Borys, D. DeAntonio, R. Guzman-Holst, A. Hoet, B.

Interchangeability between pneumococcal conjugate vaccines for pediatric use: a systematic literature review

  • Children
  • Newborn
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2020 ∙ de Sévaux, J. L. Venekamp, R. P. Lutje, V. Hak, E. Schilder, A. G. Sanders, E. A. Damoiseaux, R. A.

Pneumococcal conjugate vaccines for preventing acute otitis media in children

  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2020 ∙ Zakiyah, N. Insani, W. N. Suwantika, A. A. van der Schans, J. Postma, M. J.

Pneumococcal vaccination for children in Asian countries: A systematic review of economic evaluation studies

  • South-East Asia
  • Western Pacific
  • Children
  • Pneumococcal disease
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2020 ∙ Alizadeh Chamkhaleh, M. Esteghamati, A. Sayyahfar, S. Gandomi-Mohammadabadi, A. Balasi, J. Abdiaei, H. Moradi, Y. Moradi-Lakeh, M.

Serotype distribution of Streptococcus pneumoniae among healthy carriers and clinical patients: a systematic review from Iran

  • Eastern Mediterranean
  • Islamic Republic of Iran
  • All age groups
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2020 ∙ Kuehne, F. Sanftenberg, L. Dreischulte, T. Gensichen, J.

Shared decision making enhances pneumococcal vaccination rates in adult patients in outpatient care

  • Adults
  • Older adults
  • Pneumococcal disease
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2020 ∙ Silva, S. M. Rodrigues, I. C. G. Santos, R. D. S. Ternes, Y. M. F.

The direct and indirect effects of the pneumococcal conjugated vaccine on carriage rates in children aged younger than 5 years in Latin America and the Caribbean: a systematic review

  • Americas
  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2020 ∙ Marra, F. Zhang, A. Gillman, E. Bessai, K. Parhar, K. Vadlamudi, N. K.

The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...